Rivas 2021 COM Poster Session.JPG

First, thanks to those who helped with the poster session and those who showed up to support the trainees! The event was a big success, and everyone seemed to have a good time! Here are the winners:

Postdoc Category – Invited to speak at the Dean’s Distinguished Lecture Series in early May

1st place – Dr. Lindsey R. Conroy – Markey Cancer Center – “Visualization of lung tumor microenvironmental glycogen by next generation digital pathology” – winner of $700


LEXINGTON, Ky. (April 1, 2021) – The STEM Through Authentic Research and Training (START) program at the University of Kentucky is creating a unique pipeline to increase science, technology, engineering and math (STEM) literacy and promote STEM careers for traditionally underrepresented populations (people of color, individuals with disabilities, students from free or reduced lunch schools), first-generation college students, and girls and women in STEM.


LEXINGTON, Ky. (Jan. 22, 2021) — While the Pfizer and Moderna COVID-19 vaccines continue to be administered across the United States under an emergency authorization status, ongoing coronavirus vaccine research and development remain critical to the fight against the global pandemic.

The emergency authorization allows us to protect people now, but research will continue for decades, says University of Kentucky College of Medicine vaccine researcher Jerry Woodward.


Lyme disease is the most common vector-borne bacterial disease in the U.S., with 200,000 new cases each year. While incidence in Kentucky typically has been relatively low, the incidence of the tick vector, lxodes scapularis, has increased over the past five years, even spreading to areas it did not previously live.


LEXINGTON, Ky. (Sept. 17, 2020) — A new University of Kentucky College of Medicine study may provide answers for why so many COVID-19 patients experience thrombosis, or the formation of blood clots that obstruct blood flow through the circulatory system.

The COVID-19 pandemic has created an ever-changing environment requiring quick adjustment, especially in the field of research. In response to the pandemic, scientists at UK ceased non-essential research activity in the spring, and education was moved to online platforms. While these measures were necessary to ensure safety for faculty and learners, graduate students in the University of Kentucky College of Medicine Integrated Biomedical Sciences (IBS) PhD program saw their progress interrupted.
SOPS Photo.jpg

LEXINGTON, Ky. (Aug. 18, 2020) — The University of Kentucky Society of Postdoctoral Scholars (SOPS) hosted their first Research Pitch Competition where 19 postdocs and fellows showcased their research with one-minute elevator pitches.


LEXINGTON, Ky. (Aug. 13, 2020) — PDS Biotechnology, a clinical stage immunotherapy company, has announced positive results from preclinical testing conducted at the University of Kentucky College of Medicine of its COVID-19 vaccine candidate, PDS0203. 


Throughout the summer the University of Kentucky College of Medicine has been part of a University-wide pilot program aiming to help boost resumes and build important skills for both UK and non-UK students.

The Summer Badge Program is not your average summer school. The program provides an opportunity for learners to complete courses and earn digital badges, regardless of their current major, with the badges certifying competency in a specific skill.

DOrazio Mentor Award.png
Congratulations to Dr. Sarah D’Orazio who was a recipient for this year’s University-wide “Excellent Research Mentor Award”. Dr. D’Orazio has worked to cultivate the careers of numerous graduate, undergraduate, and High School Students. This award reflects her commitment and success in supporting the teaching and research missions of MIMG.
Jerry Woodward.JPG

LEXINGTON, Ky. (May 11, 2020) — University of Kentucky researchers have launched antibody testing that will help to understand what immunity to COVID-19 really means. Several research labs and core facilities within UK’s Colleges of Medicine and Pharmacy will be testing the antibodies of recovered COVID-19 patients for a study to see how long they protect against reinfection.

Clinical leaders from the University of Kentucky’s Markey Cancer Center, College of Medicine and College of Pharmacy have launched a clinical trial for experimental therapies to treat patients infected with COVID-19. The trial will investigate the effectiveness of azithromycin, ivermectin and camostat mesylate—drugs that could inhibit replication of SARS-CoV-2, the virus that causes the disease.

Subbarao Bondada, professor of microbiology in the Department of Microbiology, Immunology and Molecular Genetics in the University of Kentucky College of Medicine and Markey Cancer Center, has been named a Fellow of the American Association for the Advancement of Science (AAAS). Election as an AAAS Fellow is an honor bestowed upon AAAS members by their peers.


Our own Dr. Subba Bondada has been elected to the rank of AAAS Fellow in the Section on Medical Sciences by the Council of the American Association for the Advancement of Science.

From Dr. Bondada's award letter: Each year the Council elects members whose “efforts on behalf of the advancement of science or its applications are scientifically or socially distinguished.” On behalf of the Council of the American Association for the Advancement of Science, I am very pleased to inform you of your election to the rank of AAAS Fellow.

Congratulations Dr. Bondada!

Halloween 2019.jpg

Members of Microbiology, Immunology, and Molecular Genetics and staff in the Office of Biomedical Education enjoyed the opportunity to show off their Halloween outfits!

2019 3MT Winners.jpg

Eleven presenters participated in the 3 Minute Thesis Competition at the Fifth Annual Infectious Diseases Research Day held on October 17, 2019.

From left to right:

3rd place is Taylor Lundy, Graduate Student in Dr. Sylvie Garneau-Tsodikova's lab in the Department of Pharmaceutical Sciences

2nd place is Gabrielle Keb, Graduate Student in Dr. Ken Fields' lab in the Department of Microbiology, Immunology, and Molecular Genetics

Sinai - credit Ben Corwin.jpeg

A unique partnership between an engineer and a scientist at the University of Kentucky has produced data that is challenging prevailing wisdom about a potentially life-threatening parasite's behavior and revealing possible targets for treatment.

GettyImages-943431290 (1).jpg

Decades of research and treatment advances have helped extend the lives of many people living with HIV, but while these patients live longer, their risk of developing dangerous blood clots increases as much as tenfold. Blood clots – also known as thrombi – can wreak havoc on the body, causing events such as debilitating strokes and heart attacks.

Beth Oates.png
Beth Oates has been selected as the American Society for Microbiology (ASM) Young Ambassador to Kentucky. As the Ambassador for Kentucky, Beth is starting an ASM student chapter at the University of Kentucky. With the Chapter, she hopes to connect undergraduate students, graduate students and PhD students that perform research or are interested in microbiology throughout the University. If you are interested in Beth's ASM ambassador initiatives and for information on joining the ASM student chapter, email Beth at alice.oates@uky.edu.
Gabby Keb_1.jpg
4th year MIMG Ph.D. student Gabrielle Keb has been awarded a NIH F31—Ruth L. Kirschstein National Research Service Predoctoral Fellowship. The award from NIAID, entitled “Chlamydia trachomatis Secreted Effector Proteins: Infection Properties and Identification of Host Targets” will directly support her dissertation work and facilitate additional career development. Reviewers were particularly positive about Gabby’s ability and productivity as well as the strong Ph.D. training environment at the UK COM.